443 related articles for article (PubMed ID: 23569332)
1. Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy.
Wallace JL
World J Gastroenterol; 2013 Mar; 19(12):1861-76. PubMed ID: 23569332
[TBL] [Abstract][Full Text] [Related]
2. NSAID gastropathy and enteropathy: distinct pathogenesis likely necessitates distinct prevention strategies.
Wallace JL
Br J Pharmacol; 2012 Jan; 165(1):67-74. PubMed ID: 21627632
[TBL] [Abstract][Full Text] [Related]
3. NSAID enteropathy and bacteria: a complicated relationship.
Syer SD; Blackler RW; Martin R; de Palma G; Rossi L; Verdu E; Bercik P; Surette MG; Aucouturier A; Langella P; Wallace JL
J Gastroenterol; 2015 Apr; 50(4):387-93. PubMed ID: 25572030
[TBL] [Abstract][Full Text] [Related]
4. Protons pump inhibitor treatment and lower gastrointestinal bleeding: Balancing risks and benefits.
Lué A; Lanas A
World J Gastroenterol; 2016 Dec; 22(48):10477-10481. PubMed ID: 28082800
[TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis.
Wallace JL; Syer S; Denou E; de Palma G; Vong L; McKnight W; Jury J; Bolla M; Bercik P; Collins SM; Verdu E; Ongini E
Gastroenterology; 2011 Oct; 141(4):1314-22, 1322.e1-5. PubMed ID: 21745447
[TBL] [Abstract][Full Text] [Related]
6. Nonsteroidal anti-inflammatory drugs-induced small bowel enteropathy and obscure gastrointestinal bleeding.
Pérez-Cuadrado-Robles E; Quesada-Vázquez N; Martínez-Andrés B; Sánchez-Melgarejo JF; Rubio-Mateos JM; López-Higueras A; Pérez-Cuadrado-Martínez E
Gastroenterol Hepatol; 2018 Jan; 41(1):39-40. PubMed ID: 27998630
[No Abstract] [Full Text] [Related]
7. NSAID-gastroenteropathy: new aspects of pathogenesis and prevention.
Blackler RW; Gemici B; Manko A; Wallace JL
Curr Opin Pharmacol; 2014 Dec; 19():11-6. PubMed ID: 24929967
[TBL] [Abstract][Full Text] [Related]
8. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].
;
Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):81-85. PubMed ID: 28056333
[TBL] [Abstract][Full Text] [Related]
9. Hydrogen sulphide protects against NSAID-enteropathy through modulation of bile and the microbiota.
Blackler RW; Motta JP; Manko A; Workentine M; Bercik P; Surette MG; Wallace JL
Br J Pharmacol; 2015 Feb; 172(4):992-1004. PubMed ID: 25297699
[TBL] [Abstract][Full Text] [Related]
10. Detection and prevention of NSAID-induced enteropathy.
Davies NM; Saleh JY; Skjodt NM
J Pharm Pharm Sci; 2000; 3(1):137-55. PubMed ID: 10954683
[TBL] [Abstract][Full Text] [Related]
11. Toxicity of nonsteroidal anti-inflammatory drugs in the large intestine.
Davies NM
Dis Colon Rectum; 1995 Dec; 38(12):1311-21. PubMed ID: 7497845
[TBL] [Abstract][Full Text] [Related]
12. Prevention and management of non-steroidal anti-inflammatory drugs-induced small intestinal injury.
Park SC; Chun HJ; Kang CD; Sul D
World J Gastroenterol; 2011 Nov; 17(42):4647-53. PubMed ID: 22180706
[TBL] [Abstract][Full Text] [Related]
13. The risk of upper gastrointestinal bleeding in elderly users of aspirin and other non-steroidal anti-inflammatory drugs: the role of gastroprotective drugs.
Pilotto A; Franceschi M; Leandro G; Paris F; Niro V; Longo MG; D'Ambrosio LP; Andriulli A; Di Mario F
Aging Clin Exp Res; 2003 Dec; 15(6):494-9. PubMed ID: 14959953
[TBL] [Abstract][Full Text] [Related]
14. NSAIDs and the small bowel.
Tai FWD; McAlindon ME
Curr Opin Gastroenterol; 2018 May; 34(3):175-182. PubMed ID: 29438118
[TBL] [Abstract][Full Text] [Related]
15. NSAID-induced small intestinal damage--roles of various pathogenic factors.
Takeuchi K; Satoh H
Digestion; 2015; 91(3):218-32. PubMed ID: 25791157
[TBL] [Abstract][Full Text] [Related]
16. Deciphering the pathogenesis of NSAID enteropathy using proton pump inhibitors and a hydrogen sulfide-releasing NSAID.
Blackler RW; De Palma G; Manko A; Da Silva GJ; Flannigan KL; Bercik P; Surette MG; Buret AG; Wallace JL
Am J Physiol Gastrointest Liver Physiol; 2015 Jun; 308(12):G994-1003. PubMed ID: 25882612
[TBL] [Abstract][Full Text] [Related]
17. Present status and strategy of NSAIDs-induced small bowel injury.
Higuchi K; Umegaki E; Watanabe T; Yoda Y; Morita E; Murano M; Tokioka S; Arakawa T
J Gastroenterol; 2009; 44(9):879-88. PubMed ID: 19568687
[TBL] [Abstract][Full Text] [Related]
18. Nonsteroidal anti-inflammatory drug enteropathy.
Morris AJ
Gastrointest Endosc Clin N Am; 1999 Jan; 9(1):125-33. PubMed ID: 9834321
[TBL] [Abstract][Full Text] [Related]
19. Rebleeding rate and risk factors in nonsteroidal anti-inflammatory drug-induced enteropathy.
Park J; Jeon SR; Kim JO; Kim HG; Lee TH; Cho JH; Ko BM; Lee JS; Lee MS
J Dig Dis; 2018 May; 19(5):279-287. PubMed ID: 29696804
[TBL] [Abstract][Full Text] [Related]
20. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs.
Prescrire Int; 2011 Sep; 20(119):216-9. PubMed ID: 21954519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
